Moderna (MRNA)
(Real Time Quote from BATS)
$161.81 USD
-1.52 (-0.93%)
Updated May 23, 2024 11:52 AM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Brokerage Reports
Moderna, Inc. [MRNA]
Reports for Purchase
Showing records 221 - 240 ( 255 total )
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Coronavirus Note, Vol.3: Testing Grows as More Diagnostics Come Online
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Yas'' Weekly Recap of Our Key Notes and 19 Doc Calls Upcoming in 1H20
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Takeaways from Our Deep Dive mRNA Vaccine Call with Mgmt
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Coronavirus Crisis Update- Infections Moving West
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Yas'' Weekly Recap of Our Key Notes and 8 Doc Calls Upcoming in 1H20
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
4Q19 - Prophylactics Are the Golden Ticket Going Forward for MRNA
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Dial in Friday to Hear Why MRNA''s Prophylactic Vaccines Are the Chosen Few
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Dial-in to Our Call on Why MRNA''s Prophylactic Vaccines Are the Chosen Few
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Yas'' Weekly Recap of Our Key Notes and 12 Doc Calls Upcoming in 1H20
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
mRNA Vaccines Teach Old Dog a New Trick for Coronavirus
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Healthcare - Yas'' Weekly Recap of Our Key Notes and 9 Doc Calls Upcoming in 1Q20
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y